GlassScriptPhysician profile
Taylor Truong
NPI 1104542935
$2,146.80
in general payments reported to CMS, 2019-2025
13 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $540 · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.86 |
| Education | $133.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $634.30 | 2024-2025 | Tremfya, Simponi, Stelara |
| Regeneron Healthcare Solutions, INC. | $531.32 | 2024-2025 | Dupixent |
| Abbvie INC. | $365.75 | 2024-2025 | |
| Genzyme Corporation | $155.54 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $97.80 | 2024 | Sotyktu |
| Amgen INC. | $72.25 | 2024-2025 | Otezla |
| Lilly USA, LLC | $65.29 | 2024 | Ebglyss, Taltz, Zepbound |
| Incyte Corporation | $59.21 | 2024 | Opzelura |
| Strata Skin Sciences, INC. | $45.26 | 2025 | Xtrac |
| Ucb, INC. | $40.93 | 2024 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $32.09 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $23.64 | 2025 | Zoryve |
| Botanix Sb INC | $23.42 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Truong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.